공부해 봅시다/Pathology

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

Anonymous Pathologist 2013. 4. 16. 09:20

Reference: Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Mar 1;31(7):860-7. PubMed PMID: 23341518.




Tumor-infiltrating lymphocyte (TIL) 을 H&E 슬라이드만을 가지고 평가할 수 있다니..

뭐 못할건 없겠지만..


좀 용감한 듯...

저작자표시 비영리 동일조건

'공부해 봅시다 > Pathology' 카테고리의 다른 글

Initial Clinical Sensitivity and Acquired Resistance to MET Inhibition in MET-Mutated Papillary Renal Cell Carcinoma  (0) 2013.04.23
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors  (0) 2013.04.16
Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater  (0) 2013.03.31
Treatment of HCV Infection by Targeting MicroRNA  (0) 2013.03.30
지금 알고 있는 것을 그 때도 알았더라면...  (0) 2013.03.26

'공부해 봅시다/Pathology'의 다른글

  • 현재글Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

관련글

티스토리툴바